Dementia Discovery
Venture capitalLondon · Pre-Seed–Series C · 16 people tracked
Also known as Dementia Discovery Fund
Find your way into Dementia Discovery
810 people in our graph share verified history with the Dementia Discovery team — schools, employers, funds. One of them is your warm intro.
Investment thesis
DDF backs bold entrepreneurs across the full spectrum of company and asset stages within dementia therapeutics, and creates new biotech companies itself where none exist. Its mandate is to interrogate novel hypotheses and expand the breadth of targets and mechanisms for dementia therapies, investing in early-stage projects from target identification onward to translate novel biology into disease-modifying drugs. Covering Alzheimer's and other dementias such as PDD, FTD, ALS and HD, the fund pursues a dual mandate of delivering measurable patient impact and generating strong financial returns, drawing on a network of venture partners, entrepreneurs, scientists and strategic pharmaceutical partners.
Source: firm website, verified Aug 3, 2026.
Team · 16 people
from curated & public directories
Founder mafia
2 people who came through Dementia Discovery went on to found or lead other companies.
What they invest in
from 4 of 4 portfolio companiesBiotech ×4Deep Tech ×3Healthtech ×3Medical Devices ×2AI & Machine Learning ×1Digital Health ×1
HQs:United States×3United Kingdom×1
Investments · 4 tracked
founders shown can be your intro pathViolet is a therapeutics company developing small molecule treatments for central nervous system diseases, using its proprietary C-to-C Engine platform to identify disease-relevant cell-to-cell interactions.
BiotechDeep TechCambridge, US
Board seatJonathan Behr· per SEC Form D
Co-investorsOno Venture Investment, Inc.SV Health InvestorsUTECDementia Discovery Fund
AviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
BiotechDeep TechDigital HealthHealthtech
Chris Shaw(Co-Founder & Chief Scientific and Clinical Advisor)inDo Young Lee(Co-Founder)Youn Bok Lee(Co-Founder)inLisa Deschamps(Chief Executive Officer)inGraeme Fielder(Chief Operating Officer)inAlex Bloom(Chief Development Officer)in
Co-investorsAdvent Life SciencesF-Prime CapitalLifeArc VenturesMonograph Capital PartnersNew Enterprise Associates (NEA)
Cerevance develops precision novel therapeutics for central nervous system disorders, particularly neurodegenerative diseases, using its proprietary NETSseq platform and machine learning to identify targets from an extensive collection of human brain tissue samples.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesBoston, US
Craig Thompson(Chief Executive Officer)inSagar Vaidya(Chief Medical Officer)inCarrie Ann Cook(Chief Business Officer)Mark Carlton(Chief Scientific Officer)inOttavio V. Vitolo(Chief Medical Officer)in
Co-investorsForesite CapitalGV (Google Ventures)Dementia Discovery FundSV Life SciencesLightstone VenturesSV Health Investors+3 more
SV Health Investors is a global private equity and venture capital investment platform specializing in healthcare across biotechnology, medical devices, and healthcare growth equity.
BiotechHealthtechMedical DevicesBoston, US
Co-investorsDementia Discovery Fund
Portfolio news
latest coverage across their companiesCerevance · citybiz.co · May 12, 2026
Frequently asked questions
- What stage does Dementia Discovery invest at?
- Dementia Discovery invests at the Pre-Seed, Seed, Series A, Series B, Series C stages.
- What sectors does Dementia Discovery focus on?
- Dementia Discovery focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Longevity, Medical Devices.
- Where is Dementia Discovery located?
- Dementia Discovery is headquartered in London, GB.
- Does Dementia Discovery lead rounds?
- Dementia Discovery typically participates in rounds rather than leading them.
- Who does Dementia Discovery co-invest with?
- Dementia Discovery most often shares deals with SV Health Investors, F-Prime Capital, GV (Google Ventures), among 11 tracked co-investors.
Media · Podcasts & interviews
featuring the team
Similar investors
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Tenmile is an Australia-based venture firm investing in health and life sciences companies from seed stage onward, aiming to connect Australian innovation to global markets.
Portfolia operates venture funds designed by and for women, enabling members to invest collectively in innovative companies while learning together through curated content, founder access, and hands-on deal flow.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Equitage Ventures is an early-stage investor providing capital, distribution, and strategic guidance to entrepreneurs addressing the physical, mental, spiritual, and social needs of older adults across the senior care continuum.